Republished with permission from Co-Diagnostics November 12, 2025, press release: HERE.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Co-Diagnostics has formed a joint venture (CoMira Diagnostics) in Saudi Arabia, marking significant international growth for the Utah-based molecular diagnostics company into the Middle East and North Africa markets.
- Both Governor Spencer Cox and BioUtah President/CEO Kelvyn Cullimore publicly recognized Co-Diagnostics' achievement, with the Governor specifically noting the company is "competing on the world stage" and reflects Utah's life sciences strength.
- Co-Diagnostics has been recognized as an Elite member of BioUtah, underscoring its leadership position within Utah's rapidly growing life sciences community—one of the fastest growing in the United States.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.
About BioUtah
BioUtah is an independent 501(c)(6) trade association serving Utah's life sciences industry. Its member companies reflect a broad spectrum of strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and diagnostics, amongst others; and are a key driver of Utah's economy and advancing healthcare.
Contacts:
Denise Bell
[email protected]
Source: BioUtah
Distributed by: Reportable, Inc.
